Skip to Content
Merck
  • Increased AT2R expression is induced by AT1R autoantibody via two axes, Klf-5/IRF-1 and circErbB4/miR-29a-5p, to promote VSMC migration.

Increased AT2R expression is induced by AT1R autoantibody via two axes, Klf-5/IRF-1 and circErbB4/miR-29a-5p, to promote VSMC migration.

Cell death & disease (2020-06-10)
Yan Sun, Yang Li, Meili Wang, Mingming Yue, Lina Bai, Jingwei Bian, Weiwei Hao, Jing Sun, Suli Zhang, Huirong Liu
ABSTRACT

Vascular remodeling can be caused by angiotensin II type 1 receptor (AT1R) autoantibody (AT1-AA), although the related mechanism remains unknown. Angiotensin II type 2 receptor (AT2R) plays multiple roles in vascular remodeling through cross-talk with AT1R in the cytoplasm. Here, we aimed to explore the role and mechanism of AT2R in AT1-AA-induced vascular smooth muscle cell (VSMC) migration, which is a key event in vascular remodeling. In vitro and in vivo, we found that AT2R can promote VSMC migration in AT1-AA-induced vascular remodeling. Moreover, AT2R expression was upregulated via Klf-5/IRF-1-mediated transcriptional and circErbB4/miR-29a-5p-mediated posttranscriptional mechanisms in response to AT1-AA. Our data provide a molecular basis for AT1-AA-induced AT2R expression by transcription factors, namely, a circular RNA and a microRNA, and showed that AT2R participated in AT1-AA-induced VSMC migration during the development of vascular remodeling. AT2R may be a potential target for the treatment of AT1-AA-induced vascular diseases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
PD 123,319 di(trifluoroacetate) salt hydrate, powder, ≥98% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human QKI
Sigma-Aldrich
MISSION® esiRNA, targeting human IRF1
Sigma-Aldrich
MISSION® esiRNA, targeting human ADAR
Sigma-Aldrich
Angiotensin II human, ≥93% (HPLC), powder